These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18475175)

  • 1. Drug-drug interactions with immunosuppressive agents: review of the in vitro functional assays and role of cytochrome P450 enzymes.
    Elbarbry FA; Marfleet T; Shoker AS
    Transplantation; 2008 May; 85(9):1222-9. PubMed ID: 18475175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.
    Wang J
    Expert Rev Mol Diagn; 2009 May; 9(4):383-90. PubMed ID: 19435458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytochrome P450 in antiretroviral drug interactions.
    Walubo A
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):583-98. PubMed ID: 17696808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP enzymes and adverse drug reactions.
    Wynn RL; Meiller TF
    Gen Dent; 1998; 46(5):436-8. PubMed ID: 10202487
    [No Abstract]   [Full Text] [Related]  

  • 6. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
    Kumar G; Lau H; Laskin O
    Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy in the heart transplant recipient: part IV: drug-drug interactions.
    Page RL; Miller GG; Lindenfeld J
    Circulation; 2005 Jan; 111(2):230-9. PubMed ID: 15657387
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of cytochrome P450 enzymes in pharmaceutical preparations].
    Baede van Dijk PA; de Graeff PA; Lekkerkerker JF
    Ned Tijdschr Geneeskd; 1999 Dec; 143(52):2607-11. PubMed ID: 10633805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 and its role in veterinary drug interactions.
    Trepanier LA
    Vet Clin North Am Small Anim Pract; 2006 Sep; 36(5):975-85, v. PubMed ID: 16984823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized immunosuppressive therapy in pediatric heart transplantation: Progress, pitfalls and promises.
    Xie HG
    Pharmacol Ther; 2010 May; 126(2):146-58. PubMed ID: 20153366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
    Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 enzymes and the heart.
    Chaudhary KR; Batchu SN; Seubert JM
    IUBMB Life; 2009 Oct; 61(10):954-60. PubMed ID: 19787709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between human cytochrome P450 enzymes and steroids: physiological and pharmacological implications.
    Zhang YY; Yang L
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):621-9. PubMed ID: 19473111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of CYP-mediated drug interactions in vivo using in vitro data.
    Foti RS; Wahlstrom JL
    IDrugs; 2008 Dec; 11(12):900-5. PubMed ID: 19051152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450s in the development of target-based anticancer drugs.
    Purnapatre K; Khattar SK; Saini KS
    Cancer Lett; 2008 Jan; 259(1):1-15. PubMed ID: 18053638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 polymorphism--molecular, metabolic and pharmacogenetic aspects. I. Mechanisms of activity of cytochrome P450 monooxygenases.
    Pachecka J; Tomaszewski P; Kubiak-Tomaszewska G
    Acta Pol Pharm; 2008; 65(3):303-6. PubMed ID: 18646549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-related drug metabolism and cytochrome P450 enzymes.
    Andrade A; Flexner C
    AIDS Clin Care; 2000 Nov; 12(11):91-5. PubMed ID: 12211165
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytochrome p450-mediated cardiovascular drug interactions.
    Cheng JW
    Heart Dis; 2000; 2(3):254-8. PubMed ID: 11728266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450: another player in the myocardial infarction game?
    Sunder-Plassmann R
    Adv Clin Chem; 2007; 43():229-80. PubMed ID: 17249386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.